Certain agents have been used in the treatment of SJS/TEN, including cyclophosphamide and cyclosporine, among with cyclosporin has exhibited some therapeutic success. Intravenous immunoglobulin (IVIG) treatment has shown some promise in reducing the length of the reaction and improving symptoms
Stevens-Johnson syndrome future or investigational therapies
Stevens-Johnson syndrome cost-effectiveness of therapy
Eczema future or investigational therapies
Alopecia future or investigational therapies
Stevens-Johnson syndrome other diagnostic studies
Stevens-Johnson syndrome risk factors
Psoriasis future or investigational therapies
Stevens-Johnson syndrome differential diagnosis